Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93878 | 0.97 | — | — | |
| Iodide SCHEMBL10496390 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL5548850 | 0.93 | — | — | |
| SCHEMBL10425474 | 0.93 | TSHR (0.45) | — | |
| SCHEMBL31678989 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL756005 | 0.90 | — | — | |
| Allylamine SCHEMBL2360384 | 0.90 | ALDH1A1 (0.56) | — | |
| Hydrochloric Acid SCHEMBL23277188 | 0.88 | TSHR (0.50) | — | |
| Hydrochloric Acid SCHEMBL11575636 | 0.88 | TSHR (0.50) | — | |
| Hydrochloric Acid SCHEMBL756257 | 0.88 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4740942-A1 | AROMATIC AMIDE DERIVATIVE AND USE THEREOF | HUAJIAN FUTURE (CHENGDU) TECHNOLOGY CO., LTD. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-12297205-B2 | Macrocyclic compounds for treatment of medical disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-20250074911-A1 | MACROCYCLIC BTK INHIBITORS | CROSSFIRE ONCOLOGY HOLDING B.V. (NL) | 2025-03-06 | — | — | US | disclosed |
| WO-2025007811-A1 | AROMATIC AMIDE DERIVATIVE AND USE THEREOF | 成都华健未来科技有限公司 | 2025-01-09 | — | — | WO | disclosed |
| EP-4448523-A1 | MACROCYCLIC BTK INHIBITORS | Crossfire Oncology Holding B.V. (NL) | 2024-10-23 | — | — | EP | disclosed |
| US-20240327842-A1 | GALNAC-MONOMERS AND GALNAC-NUCLEIC ACID CONJUGATES | LERNA BIOPHARMA PTE. LTD. (SG) | 2024-10-03 | — | — | US | disclosed |
| CN-118696041-A | Macrocyclic BTK inhibitors | 克罗斯费尔肿瘤学控股有限公司 | 2024-09-24 | — | — | CN | disclosed |
| EP-4384528-A2 | GALNAC-MONOMERS AND GALNAC-NUCLEIC ACID CONJUGATES | Lerna Biopharma Pte. Ltd. (SG) | 2024-06-19 | — | — | EP | disclosed |
| CN-117858883-A | GalNAc monomer and GalNAc oligonucleotide conjugate | 莱尔纳生物制药私人有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20240059702-A1 | MACROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2024-02-22 | — | — | US | disclosed |
| US-7678784-B2 | Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-03-16 | — | — | US | disclosed |
| US-20100029701-A1 | MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK SHARP & DOHME LLC | 2010-02-04 | — | — | US | disclosed |
| US-20080139523-A1 | OXIME-CONTAINING MACROCYCLIC ACYL GUANIDINES AS BETA-SECRETASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-06-12 | — | — | US | disclosed |
| EP-1375593-B1 | Resin composition | NIPPON CATALYTIC CHEM IND (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1158031-B1 | Aqueous fast-drying resin composition and its production process and use | NIPPON CATALYTIC CHEM IND (JP) | 2004-12-15 | — | — | EP | disclosed |
| EP-1375593-A1 | Resin composition | Nippon Shokubai Co., Ltd. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20040002561-A1 | Waterproofing; discoloration inhibition; blocking resistance; addition-condensation copolymers; cation polymers | NIPPON SHOKUBAI CO., LTD. | 2004-01-01 | — | — | US | disclosed |
| US-6596805-B1 | Resistance on a level with those of solvent type compositions; a production process for the aqueous fast-drying resin composition; and a use of the aqueous fast-drying resin composition as a gravure | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-07-22 | — | — | US | disclosed |
| US-6566426-B1 | Driability, and which is excellent in adhesion; water and solvent resistances | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-05-20 | — | — | US | disclosed |
| EP-1158031-A1 | Aqueous fast-drying resin composition and its production process and use | Nippon Shokubai Co., Ltd. (JP) | 2001-11-28 | — | — | EP | disclosed |